{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Merck", "item": "https://www.patentleaderboard.com/2021/company/merck"}, {"@type": "ListItem", "position": 4, "name": "Ali Amjad", "item": "https://www.patentleaderboard.com/2021/inventor/fl:al_ln:amjad-1"}]}

Home › 2021 › Merck › Ali Amjad

Ali Amjad — 1 Patent in 2021

Merck: 1 patents #304 of 909Top 35%

Edison, NJ: #51 of 161 inventorsTop 35%

New Jersey: #2,278 of 6,977 inventorsTop 35%

Overall (2021): #541,261 of 548,734Top 100%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11046714	2,2-difluorodioxolo A2A receptor antagonists	Gioconda V. Gallo, Timothy J. Henderson, Rongze Kuang, Yeon-Hee Lim, Michael Man-Chu Lo +6 more	2021-06-29	$135,073,000

Ali Amjad — 1 Patent in 2021

Issued Patents 2021

Patent Widget